AION Labs

Company profile

AION Labs company profile

AION Labs is a groundbreaking venture studio established by AstraZeneca, Merck, Pfizer, Teva, the Israel Biotech Fund, Amiti Ventures, and AWS, with support from BioMed X. Our mission is to revolutionize drug discovery and development by developing and integrating advanced AI technologies. Through our unique venture studio model, we create startups that combine global pharmaceutical expertise with cutting-edge AI and biotechnology. This approach reduces risk by fostering cross-industry partnerships, enabling seamless data sharing, and providing unparalleled access to pharma R&D expertise. Our model accelerates the path to market for startups, empowering them to create and validate transformative solutions for the biotech industry. To date, AION Labs has launched and invested in nine innovative startups, led by visionary founders, driving an AI-powered revolution in biotech.